Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Malignant Melanoma

  Free Subscription


Articles published in Am J Dermatopathol

Retrieve available abstracts of 51 articles:
HTML format



Single Articles


    April 2025
  1. VAVRUKH P, LeBlanc RE, Yan S
    Diagnostic Utility of Preferentially Expressed Antigen in Melanoma (PRAME) and p16 Immunohistochemistry in Distinguishing Genital Melanomas From Benign Melanocytic Proliferations.
    Am J Dermatopathol. 2025 Apr 22. doi: 10.1097/DAD.0000000000002977.
    PubMed     Abstract available


    March 2025
  2. SHAKER N, Niu S, Blankenship H, Shaker N, et al
    Artificial Intelligence and Convolutional Neural Networks-Driven Detection of Micro and Macro Metastasis of Cutaneous Melanoma to the Lymph Nodes.
    Am J Dermatopathol. 2025 Mar 19. doi: 10.1097/DAD.0000000000002954.
    PubMed     Abstract available


    February 2025
  3. GAO Y, Yang RK, Curry JL, Torres-Cabala CA, et al
    Melanoma With RNF11::BRAF Fusion: A Novel Fusion Previously Undescribed in Melanoma.
    Am J Dermatopathol. 2025 Feb 25. doi: 10.1097/DAD.0000000000002936.
    PubMed     Abstract available


  4. KOGA S, Karakousis GC, Yang G, Elder DE, et al
    Late Recurrent Spitz Melanoma With a TMEM106B::BRAF Fusion.
    Am J Dermatopathol. 2025 Feb 19. doi: 10.1097/DAD.0000000000002946.
    PubMed     Abstract available


  5. SHAKER N, Phelps R, Niedt G, Sangueza O, et al
    BRCA1-Associated Protein-1 Inactivated Melanoma Arising in a Pre-existing Nevus With ALK Fusion and Low Tumor Mutational Burden.
    Am J Dermatopathol. 2025 Feb 6. doi: 10.1097/DAD.0000000000002925.
    PubMed     Abstract available


  6. KNITTEL RJ, Harvey NT, Ardakani NM, O'Brien B, et al
    Clinicopathologic Features of PRAME-Positive Common Melanocytic Nevi: A Case-Control Study.
    Am J Dermatopathol. 2025 Feb 6. doi: 10.1097/DAD.0000000000002932.
    PubMed     Abstract available


    December 2024
  7. TIRUMALAE R, Correa M, Manjunath S
    Intramuscular Cellular Nodules in a Congenital Large Plaque-Like Blue Nevus: Melanoma or Not?
    Am J Dermatopathol. 2024 Dec 31. doi: 10.1097/DAD.0000000000002906.
    PubMed     Abstract available


  8. FERNANDEZ-FLORES A
    "Pathway Leap": A New Molecular Phenomenon to Consider in the Pathogenesis of Melanocytic Tumors.
    Am J Dermatopathol. 2024 Dec 31. doi: 10.1097/DAD.0000000000002916.
    PubMed     Abstract available


  9. YAVUZ A, Simsek K, Bassorgun CI, Elpek GO, et al
    The Prognostic Significance of Tumor Budding and Tumor-Infiltrating Lymphocytes in Patients Diagnosed With Malignant Melanoma.
    Am J Dermatopathol. 2024 Dec 10. doi: 10.1097/DAD.0000000000002902.
    PubMed     Abstract available


    October 2024
  10. FERNANDEZ-FLORES A
    Selective Clonal Regression After Interferon Therapy in Metastatic Melanoma.
    Am J Dermatopathol. 2024 Oct 31. doi: 10.1097/DAD.0000000000002873.
    PubMed     Abstract available


  11. KOSSARD S, Sharifi S, Calvey L
    Utilizing PRAME Expression and a Meta-Analytic Framework for iSALT to Explore Atypical Late-Onset Nevi of the Elderly and Their Relationship With Lentiginous and Nested Nevoid Melanomas.
    Am J Dermatopathol. 2024 Oct 15. doi: 10.1097/DAD.0000000000002847.
    PubMed     Abstract available


  12. ASATO MA, Moraes Neto FA, Moraes MPT, Ocanha-Xavier JP, et al
    The Utility of PRAME and Ki-67 as Prognostic Markers for Cutaneous Melanoma.
    Am J Dermatopathol. 2024 Oct 15. doi: 10.1097/DAD.0000000000002863.
    PubMed     Abstract available


    September 2024
  13. DARUISH M, Kerr G, Taibjee S
    A Combined Spindle Cell Melanoma and Sarcomatoid Squamous Cell Carcinoma: A Rather Unique Squamomelanocytic Tumor.
    Am J Dermatopathol. 2024 Sep 17. doi: 10.1097/DAD.0000000000002838.
    PubMed     Abstract available


  14. SINGH P, Wu D, Karunamurthy A, Seynnaeve BKN, et al
    Pediatric Melanoma With a Rare BRAF V600K Mutation.
    Am J Dermatopathol. 2024 Sep 17. doi: 10.1097/DAD.0000000000002835.
    PubMed    


  15. RUZ PORTERO B, Garcia de Sola Llamas C, Perez Perez M, Sanchez Bernal ML, et al
    Cellular Schwannoma Mimicking a Nodular Melanoma on the Sole of the Foot, an Avoidable Diagnostic Pitfall.
    Am J Dermatopathol. 2024;46:e79-e83.
    PubMed     Abstract available


    August 2024
  16. VAN SAMBEEK S, Friedlander E, Patino WD
    A Retrospective Review: Our Experience With an Adhesive-Based Pigmented Lesion Assay Used to Evaluate Cutaneous Lesions Suspicious for Melanoma.
    Am J Dermatopathol. 2024 Aug 14. doi: 10.1097/DAD.0000000000002759.
    PubMed     Abstract available


  17. DARUISH M, Karunaratne S, Duffy-Gadd P, Hansford S, et al
    Utility of PRAME Immunohistochemistry in the Detection of Subtle Melanoma Microsatellites.
    Am J Dermatopathol. 2024 Aug 14. doi: 10.1097/DAD.0000000000002817.
    PubMed     Abstract available


  18. NG S, Hall KC, Busam KJ, Lezcano C, et al
    Superficial Wnt-Activated Melanocytic Nevi/Melanocytomas With a Junctional Component: A Case Series.
    Am J Dermatopathol. 2024 Aug 14. doi: 10.1097/DAD.0000000000002804.
    PubMed     Abstract available


  19. GOLDBERG MS, Cockerell CJ, Rogers JH, Siegel JJ, et al
    Appropriate Statistical Methods to Assess Cross-study Diagnostic 23-Gene Expression Profile Test Performance for Cutaneous Melanocytic Neoplasms.
    Am J Dermatopathol. 2024 Aug 14. doi: 10.1097/DAD.0000000000002808.
    PubMed     Abstract available


    July 2024
  20. FIELDS BC, Jain AJ, Prieto VG, Frink SJ, et al
    Pigmented Villonodular Synovitis: A Metastatic Melanoma Imitator.
    Am J Dermatopathol. 2024 Jul 12. doi: 10.1097/DAD.0000000000002771.
    PubMed     Abstract available


  21. IBRAHIM E, Yang RK, Curry JL, Cho WC, et al
    BCR::ZNF711 and BCR::CYLC2 Fusions: Novel BCR Fusions Expanding the Molecular Spectrum of Gene Fusions in Melanoma.
    Am J Dermatopathol. 2024 Jul 12. doi: 10.1097/DAD.0000000000002796.
    PubMed    


    June 2024
  22. CHO WC, Prieto VG, Yang RK
    Spitz Melanoma With SLC20A1::ALK Fusion: A Novel Fusion Previously Undescribed in Spitz Melanocytic Neoplasm.
    Am J Dermatopathol. 2024 Jun 28. doi: 10.1097/DAD.0000000000002778.
    PubMed     Abstract available


  23. CHEN JM, Hernandez E, Frosina D, Ruh PA, et al
    In Situ Protein Expression Analysis of Melanocyte Differentiation Antigen TRP1 (Tyrosinase-Related Protein-1).
    Am J Dermatopathol. 2024 Jun 28. doi: 10.1097/DAD.0000000000002772.
    PubMed     Abstract available


  24. MERT M, Bozdogan O, Bozdogan N, Gamsizkan M, et al
    PRAME and Historical Immunohistochemical Antibodies Ki-67, P16, and HMB-45 in Ambiguous Melanocytic Tumors.
    Am J Dermatopathol. 2024 Jun 20. doi: 10.1097/DAD.0000000000002768.
    PubMed     Abstract available


  25. KNITTEL R, Rogers S, Wood BA
    Cutaneous Seeding of Glioblastoma: A Case Report and Literature Review.
    Am J Dermatopathol. 2024 Jun 6. doi: 10.1097/DAD.0000000000002748.
    PubMed     Abstract available


    May 2024
  26. LEDESMA DA, Marques-Piubelli ML, Li-Ning-Tapia E, Hudgens C, et al
    Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma.
    Am J Dermatopathol. 2024 May 7. doi: 10.1097/DAD.0000000000002635.
    PubMed     Abstract available


  27. SU S, Liu J, Jiang Y
    Rare Presentation of Melanoma Recurrences With Diffuse Subcutaneous Intravascular Lesions: A Novel In-Transit Metastases Pattern.
    Am J Dermatopathol. 2024 May 7. doi: 10.1097/DAD.0000000000002735.
    PubMed     Abstract available


    April 2024
  28. SRIVATSA S, Smith CJ, Sangueza OP, Miedema J, et al
    Lymphangitic Melanomatosis: Case Report of Intralymphatic Spread of Melanoma in a 66-year-old Man.
    Am J Dermatopathol. 2024 Apr 4. doi: 10.1097/DAD.0000000000002696.
    PubMed     Abstract available


    March 2024
  29. LOPER R, Schon MP, Mitteldorf C
    Melanocyte Density in the Diagnosis of Melanoma In Situ in Sun-Damaged Skin.
    Am J Dermatopathol. 2024 Mar 19. doi: 10.1097/DAD.0000000000002680.
    PubMed     Abstract available


  30. CASILLAS AC, Muhlbauer A, Barragan VA, Jefferson I, et al
    A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations.
    Am J Dermatopathol. 2024;46:137-146.
    PubMed     Abstract available


  31. LOHMAN ME, Kim YH, Steen AJ, Demer AM, et al
    The Promise and Pitfalls of PRAME Immunohistochemistry During Mohs Surgery: Early Findings.
    Am J Dermatopathol. 2024;46:191-192.
    PubMed    


    February 2024
  32. MACHUCA-AGUADO J, Garcia-Trevijano CI, Orrego-Pereira C, Montana-Ramirez AM, et al
    Unraveling PRAME Expression in Desmoplastic Melanocytic Neoplasms: Illuminating its Diagnostic Significance in Distinguishing Desmoplastic Spitz Nevi.
    Am J Dermatopathol. 2024 Feb 7. doi: 10.1097/DAD.0000000000002638.
    PubMed    


    January 2024
  33. WILLS A, Dibbern M, Frierson HF, Raghavan SS, et al
    Metastatic Undifferentiated Melanoma Mimicking a Primary Bone Tumor: A Potential Diagnostic Pitfall.
    Am J Dermatopathol. 2024 Jan 3. doi: 10.1097/DAD.0000000000002622.
    PubMed     Abstract available


    December 2023
  34. MCTIGHE SP, Taylor EA, Allbritton J, Lewin-Smith MR, et al
    Localized Cutaneous Argyria at the Site of a Prior Melanoma Excision Confirmed by Scanning Electron Microscopy With Energy Dispersive X-ray Analysis.
    Am J Dermatopathol. 2023 Dec 26. doi: 10.1097/DAD.0000000000002610.
    PubMed     Abstract available


    November 2023
  35. NEIMY H, Helmy JE, Snyder A, Valdebran M, et al
    Artificial Intelligence in Melanoma Dermatopathology: A Review of Literature.
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002593.
    PubMed     Abstract available


  36. KENNY MG, Nguyen M, Modi M, Eilers D, et al
    Melanoma Mimicker: Pigmented Mammary Paget Disease in a Man.
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002588.
    PubMed     Abstract available


  37. TURNER N, Ko CJ, McNiff JM, Galan A, et al
    Pitfalls of PRAME Immunohistochemistry in a Large Series of Melanocytic and Nonmelanocytic Lesions With Literature Review.
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002584.
    PubMed     Abstract available


  38. DONATI M, Grossmann P, Mansour B, Kazakov DV, et al
    Melanocytic Neoplasm With KIT and APC Mutations: A New Subtype of Melanocytoma?
    Am J Dermatopathol. 2023 Nov 14. doi: 10.1097/DAD.0000000000002556.
    PubMed     Abstract available


  39. KIM JC, Choi JW, Kim YC
    Comparison of Melanocyte-Associated Immunohistochemical Markers in Acral Lentiginous Melanoma and Acral Benign Nevi.
    Am J Dermatopathol. 2023;45:748-752.
    PubMed     Abstract available


  40. LEZCANO C, Jungbluth AA, Busam KJ
    Immunohistochemistry for PRAME in Dermatopathology.
    Am J Dermatopathol. 2023;45:733-747.
    PubMed     Abstract available


    August 2023
  41. VANDERBECK K, Rothrock AT, Cho WC, Nagarajan P, et al
    PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls.
    Am J Dermatopathol. 2023;45:549-556.
    PubMed     Abstract available


  42. WEN D, Chen T, Martin RCW
    A Rare Case of a Basomelanocytic Tumor.
    Am J Dermatopathol. 2023;45:e64-e67.
    PubMed     Abstract available


    July 2023
  43. OCANHA XAVIER JP, Xavier JCC Jr, da Silva MG, Marques MEA, et al
    Vitamin D Receptor and Retinoid X Receptor Alpha in Melanocytic Benign Lesions and Melanoma.
    Am J Dermatopathol. 2023 Jul 28. doi: 10.1097/DAD.0000000000002507.
    PubMed     Abstract available


  44. SHERIDAN C, O'Connor MC, Sitton B, Bass J, et al
    Nevus Spilus With Dermatoheliosis: A Histologic Mimicker of Melanoma in Situ at Melanoma Excision Margins.
    Am J Dermatopathol. 2023 Jul 11. doi: 10.1097/DAD.0000000000002493.
    PubMed     Abstract available


  45. BOUTKO A, Hagstrom M, Lampley N, Roth A, et al
    PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
    Am J Dermatopathol. 2023;45:437-447.
    PubMed     Abstract available


    May 2023
  46. O'NEILL P, Amanuel B, Mesbah Ardakani N
    Cutaneous Malignant Melanoma With Rhabdomyosarcomatous Dedifferentiation: an Immunohistological and Molecular Case Study With Literature Review.
    Am J Dermatopathol. 2023 May 2. doi: 10.1097/DAD.0000000000002451.
    PubMed     Abstract available


  47. MCFADDEN JR, Syku M, Barney RE, Stevanovic M, et al
    A Novel Method to Detect Copy Number Variation in Melanoma: Droplet Digital PCR for Quantitation of the CDKN2A Gene, a Proof-of-Concept Study.
    Am J Dermatopathol. 2023 May 2. doi: 10.1097/DAD.0000000000002436.
    PubMed     Abstract available


    April 2023
  48. PISANI D, Micallef D, Scerri J, Betts A, et al
    Neuroendocrine Transdifferentiation in Cutaneous Melanoma: A Case Report and Review of the Literature.
    Am J Dermatopathol. 2023;45:264-268.
    PubMed     Abstract available


  49. CORTEZ DE ALMEIDA RF, Sponchiado Assoni A, Cabrera Pereira JP, Erthal de Britto Pereira Kassuga Roisman L, et al
    Pigmented Bowen Disease in the Acral Region: A Diagnostic Challenge.
    Am J Dermatopathol. 2023;45:235-236.
    PubMed    


    March 2023
  50. MCFADDEN JR, Chaudhari AS, Stevanovic M, Tsongalis GJ, et al
    Gain of CCND1 May Occur Too Infrequently in Cutaneous Melanoma, and Too Late in Melanomagenesis, to Be Diagnostically Useful: Genomic Analysis of 88 Cases.
    Am J Dermatopathol. 2023 Mar 20. doi: 10.1097/DAD.0000000000002420.
    PubMed     Abstract available


    February 2023
  51. BOUTKO A, Asadbeigi S, Roth A, Lampley N, et al
    TERT Promoter Mutational Analysis as an Ancillary Diagnostic Tool for Diagnostically Challenging Melanocytic Neoplasms.
    Am J Dermatopathol. 2023 Feb 17. doi: 10.1097/DAD.0000000000002366.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.